Period | Age group (years), gender | n | Adherence | Inhaler competence | True adherence |
---|---|---|---|---|---|
First 45 days, morning | 5–6 | 54 | 85.9 (13.4) | 91.3 (13.9) | 78.5 (17.7) |
7–8 | 42 | 86.2 (15.0) | 94.2 (15.5) | 81.2 (20.0) | |
9–10 | 19 | 79.1 (19.5) | 98.7 (1.9) | 78.1 (19.6) | |
Boys | 71 | 83.1 (16.9) | 94.3 (11.9) | 78.3 (19.4) | |
Girls | 44 | 87.7 (11.7) | 92.5 (16.0) | 81.2 (17.7) | |
First 45 days, evening | 5–6 | 54 | 88.4 (13.6) | 93.3 (12.7) | 82.6 (17.3) |
7–8 | 42 | 89.2 (15.7) | 95.8 (14.2) | 85.5 (20.4) | |
9–10 | 19 | 83.5 (20.6) | 97.6 (4.3) | 82.1 (21.4) | |
Boys | 71 | 85.9 (17.5) | 94.9 (11.0) | 81.8 (20.1) | |
Girls | 44 | 91.2 (11.7) | 94.8 (14.4) | 86.4 (16.9) | |
Last 45 days, morning | 5–6 | 54 | 66.9 (25.6) | 94.8 (18.0) | 63.6 (26.3) |
7–8 | 42 | 52.7 (25.5) | 96.6 (14.4) | 51.4 (26.2) | |
9–10 | 19 | 44.9 (27.9) | 98.0 (5.9) | 44.0 (27.7) | |
Boys | 71 | 57.4 (28.4) | 96.4 (15.7) | 55.4 (28.5) | |
Girls | 44 | 58.9 (25.3) | 95.3 (15.0) | 56.7 (25.7) | |
Last 45 days, evening | 5–6 | 54 | 69.4 (24.4) | 95.4 (17.3) | 66.9 (25.1) |
7–8 | 42 | 62.0 (20.9) | 96.1 (15.5) | 60.5 (22.3) | |
9–10 | 19 | 52.6 (24.4) | 97.4 (7.6) | 51.8 (25.3) | |
Boys | 71 | 64.1 (24.3) | 96.2 (15.5) | 62.0 (25.2) | |
Girls | 44 | 63.7 (23.1) | 95.8 (15.4) | 61.7 (23.7) |